Treatment of Ipilimumab-Induced Vogt-Koyanagi-Harada Syndrome With Oral Dexamethasone
Author:
Publisher
SLACK, Inc.
Subject
Ophthalmology,Surgery
Reference8 articles.
1. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
2. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
3. Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
4. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature11The authors constitute the International Committee on Vogt-Koyanagi-Harada Disease Nomenclature, representing the participants of the First International Workshop on Vogt-Koyanagi-Harada Disease. A full list of participants appears at the end of the article.
5. BILATERAL DRUG (IPILIMUMAB)-INDUCED VITRITIS, CHOROIDITIS, AND SEROUS RETINAL DETACHMENTS SUGGESTIVE OF VOGT–KOYANAGI–HARADA SYNDROME
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Diagnosing and Managing Uveitis Associated with Immune Checkpoint Inhibitors: A Review;Diagnostics;2024-02-04
2. Pigmentary retinopathy associated with immune therapy for advanced cutaneous melanoma;American Journal of Ophthalmology Case Reports;2023-06
3. Checkpoint Inhibitor-Associated Vogt-Koyanagi-Harada Disease Presenting 3 Months Following Discontinuation of Nivolumab;Ophthalmic Surgery, Lasers and Imaging Retina;2023-03
4. Ocular adverse events associated with immune checkpoint inhibitors, a scoping review;Journal of Ophthalmic Inflammation and Infection;2023-02-22
5. Ocular Inflammation Induced by Immune Checkpoint Inhibitors;Journal of Clinical Medicine;2022-08-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3